Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn LoPiccolo

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|July 15, 2015
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activityAliaksei Shymanets, Prajwal, Oscar Vadas, et al.
The Journal of Biological Chemistry|October 18, 2015
Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α HomodimerJaclyn LoPiccolo, Seung Joong Kim, Yi Shi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2025
Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancersPrashasti Agrawal, Julia Rotow, Gaetano Rocco, et al.
JCO Precision Oncology|November 22, 2023
Rate of Pathogenic Germline Variants in Patients With Lung CancerSteven Sorscher, Jaclyn LoPiccolo, Brandie Heald, et al.
Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.
JAMA Network Open|March 27, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapySienna M Durbin, Leyre Zubiri, Katherine Perlman, et al.
Frontiers in Oncology|July 11, 2025
Young lung cancer: from diagnosis to survivorshipNarjust Florez, Lauren Kiel, Rebekah Kaufman, et al.
JCO Precision Oncology|June 29, 2023
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in <i>BRD4-NUTM1</i> NUT Carcinoma Harboring a <i>BRD4</i> Splice Site MutationMichael L Cheng, Yeying Huang, Nhi Luong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLCIgor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Oncotarget|October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|July 15, 2015
Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activityAliaksei Shymanets, Prajwal, Oscar Vadas, et al.
The Journal of Biological Chemistry|October 18, 2015
Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α HomodimerJaclyn LoPiccolo, Seung Joong Kim, Yi Shi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 19, 2025
Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancersPrashasti Agrawal, Julia Rotow, Gaetano Rocco, et al.
JCO Precision Oncology|November 22, 2023
Rate of Pathogenic Germline Variants in Patients With Lung CancerSteven Sorscher, Jaclyn LoPiccolo, Brandie Heald, et al.
Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.
JAMA Network Open|March 27, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapySienna M Durbin, Leyre Zubiri, Katherine Perlman, et al.
Frontiers in Oncology|July 11, 2025
Young lung cancer: from diagnosis to survivorshipNarjust Florez, Lauren Kiel, Rebekah Kaufman, et al.
JCO Precision Oncology|June 29, 2023
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in <i>BRD4-NUTM1</i> NUT Carcinoma Harboring a <i>BRD4</i> Splice Site MutationMichael L Cheng, Yeying Huang, Nhi Luong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLCIgor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Oncotarget|October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.
Pageof 4